Buprenorphine Transdermal System for Opioid Therapy in Patients with Chronic Low Back Pain

OBJECTIVE: The present randomized, double-blinded, crossover study compared the efficacy and safety of a seven-day buprenorphine transdermal system (BTDS) and placebo in patients with low back pain of moderate or greater severity for at least six weeks.

Bibliographic Details
Main Authors: Allan Gordon, Saifudin Rashiq, Dwight E Moulin, Alexander J Clark, André D Beaulieu, John Eisenhoffer, Paula S Piraino, Patricia Quigley, Zoltan Harsanyi, Andrew C Darke
Format: Article
Language:English
Published: Hindawi Limited 2010-01-01
Series:Pain Research and Management
Online Access:http://dx.doi.org/10.1155/2010/216725

Similar Items